Benzo(a)pyrene facilitates dermatophagoides group 1 (Der f 1)-induced epithelial cytokine release through aryl hydrocarbon receptor in asthma.


Journal

Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028

Informations de publication

Date de publication:
09 2019
Historique:
received: 17 09 2018
revised: 24 01 2019
accepted: 18 02 2019
pubmed: 16 4 2019
medline: 5 8 2020
entrez: 16 4 2019
Statut: ppublish

Résumé

Environmental pollutants, which coexist with allergens, have been associated with the exacerbation of asthma. However, the underlying molecular mechanisms remain elusive. We sought to determine whether benzo(a)pyrene (BaP) co-exposure with dermatophagoides group 1 allergen (Der f 1) can potentiate Der f 1-induced asthma and its underlying mechanisms. The effect of BaP was investigated in Der f 1-induced mouse model of asthma, including airway hyper-responsiveness, allergic inflammation, and epithelial-derived cytokines. The impact of BaP on Der f 1-induced airway epithelial cell oxidative stress (ROS) and cytokine release was further analyzed. The role of aryl hydrocarbon receptor (AhR) signaling in BaP-promoted Der f 1-induced ROS, cytokine production, and allergic inflammation was also investigated. Compared with Der f 1, BaP co-exposure with Der f 1 led to airway hyper-responsiveness and increased lung inflammation in mouse model of asthma. Increased expression of TSLP, IL-33, and IL-25 was also found in the airways of these mice. Moreover, BaP co-exposure with Der f 1 activated AhR signaling with increased expression of AhR and CYP1A1 and promoted airway epithelial ROS generation and TSLP and IL-33, but not IL-25, expression. Interestingly, AhR antagonist CH223191 or cells with AhR knockdown abrogated the increased expression of ROS, TSLP, and IL-33. Furthermore, ROS inhibitor N-acetyl-L-cysteine (NAC) also suppressed BaP co-exposure-induced expression of epithelial TSLP, IL-33, and IL-25. Finally, AhR antagonist CH223191 and NAC inhibited BaP co-exposure with Der f 1-induced lung inflammation. Our findings suggest that BaP facilitates Der f 1-induced epithelial cytokine release through the AhR-ROS axis.

Sections du résumé

BACKGROUND
Environmental pollutants, which coexist with allergens, have been associated with the exacerbation of asthma. However, the underlying molecular mechanisms remain elusive. We sought to determine whether benzo(a)pyrene (BaP) co-exposure with dermatophagoides group 1 allergen (Der f 1) can potentiate Der f 1-induced asthma and its underlying mechanisms.
METHODS
The effect of BaP was investigated in Der f 1-induced mouse model of asthma, including airway hyper-responsiveness, allergic inflammation, and epithelial-derived cytokines. The impact of BaP on Der f 1-induced airway epithelial cell oxidative stress (ROS) and cytokine release was further analyzed. The role of aryl hydrocarbon receptor (AhR) signaling in BaP-promoted Der f 1-induced ROS, cytokine production, and allergic inflammation was also investigated.
RESULTS
Compared with Der f 1, BaP co-exposure with Der f 1 led to airway hyper-responsiveness and increased lung inflammation in mouse model of asthma. Increased expression of TSLP, IL-33, and IL-25 was also found in the airways of these mice. Moreover, BaP co-exposure with Der f 1 activated AhR signaling with increased expression of AhR and CYP1A1 and promoted airway epithelial ROS generation and TSLP and IL-33, but not IL-25, expression. Interestingly, AhR antagonist CH223191 or cells with AhR knockdown abrogated the increased expression of ROS, TSLP, and IL-33. Furthermore, ROS inhibitor N-acetyl-L-cysteine (NAC) also suppressed BaP co-exposure-induced expression of epithelial TSLP, IL-33, and IL-25. Finally, AhR antagonist CH223191 and NAC inhibited BaP co-exposure with Der f 1-induced lung inflammation.
CONCLUSIONS
Our findings suggest that BaP facilitates Der f 1-induced epithelial cytokine release through the AhR-ROS axis.

Identifiants

pubmed: 30982974
doi: 10.1111/all.13784
pmc: PMC6790621
doi:

Substances chimiques

Allergens 0
Antigens, Dermatophagoides 0
Arthropod Proteins 0
Cytokines 0
Environmental Pollutants 0
Reactive Oxygen Species 0
Receptors, Aryl Hydrocarbon 0
Benzo(a)pyrene 3417WMA06D
Cysteine Endopeptidases EC 3.4.22.-
Dermatophagoides farinae antigen f 1 EC 3.4.22.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1675-1690

Subventions

Organisme : Shenzhen Peacock Plan Team Project
ID : 201703313000321
Pays : International
Organisme : Guangdong Province Science and Technology Planning Project
ID : 2017B020226006
Pays : International
Organisme : Shenzhen Health Planning Commission Scientific Research Project
ID : 201604130418
Pays : International
Organisme : Shenzhen Scientific Technology Basic Research Projects
ID : JCYJ20160328144536436
Pays : International
Organisme : Shenzhen Scientific Technology Basic Research Projects
ID : JCYJ20170307162947583
Pays : International
Organisme : National Natural Science Foundation of China
ID : 81628001
Pays : International
Organisme : National Natural Science Foundation of China
ID : 31770984
Pays : International
Organisme : NIEHS NIH HHS
ID : R01 ES021739
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI121768
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI137547
Pays : United States

Informations de copyright

© 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Références

Clin Immunol. 2012 Jun;143(3):222-35
pubmed: 22534317
N Engl J Med. 2006 Nov 23;355(21):2226-35
pubmed: 17124020
Nature. 2008 May 1;453(7191):65-71
pubmed: 18362915
Nat Immunol. 2018 Jun;19(6):571-582
pubmed: 29760532
J Appl Toxicol. 2016 Nov;36(11):1496-504
pubmed: 26918773
Environ Sci Technol. 2016 Jan 5;50(1):79-88
pubmed: 26595236
Immunity. 2018 Jan 16;48(1):19-33
pubmed: 29343438
Part Fibre Toxicol. 2010 Dec 16;7:41
pubmed: 21162728
Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):766-75
pubmed: 9309991
Allergy. 2018 Nov;73(11):2192-2204
pubmed: 29672862
JCI Insight. 2017 Feb 9;2(3):e88297
pubmed: 28194433
Mol Pharmacol. 2013 May;83(5):1133-40
pubmed: 23478803
J Allergy Clin Immunol. 2019 Jan;143(1):386-394.e3
pubmed: 29936100
Chem Res Toxicol. 2008 Jan;21(1):102-16
pubmed: 18076143
Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1111-25
pubmed: 17293377
Org Lett. 2010 Jun 18;12(12):2884-7
pubmed: 20507088
JCI Insight. 2017 Jan 12;2(1):e90139
pubmed: 28097237
Annu Rev Pharmacol Toxicol. 1995;35:307-40
pubmed: 7598497
Environ Res. 2018 Jul;164:327-339
pubmed: 29567418
Vascul Pharmacol. 2006 Mar;44(3):143-8
pubmed: 16309971
J Allergy Clin Immunol. 2008 Dec;122(6):1208-14
pubmed: 18926564
Front Immunol. 2015 Apr 02;6:147
pubmed: 25883597
Rev Environ Contam Toxicol. 2018;244:5-51
pubmed: 28361472
J Allergy Clin Immunol. 2015 Aug;136(2):295-303.e7
pubmed: 25748065
Immunology. 2009 Jul;127(3):299-311
pubmed: 19538249
J Allergy Clin Immunol. 2014 Jul;134(1):63-72
pubmed: 24365139
Nature. 2014 Aug 28;512(7515):387-92
pubmed: 25119038
NCHS Data Brief. 2012 May;(94):1-8
pubmed: 22617340
Am J Ind Med. 2011 Feb;54(2):157-64
pubmed: 21259299
J Occup Med Toxicol. 2009 Jun 29;4:17
pubmed: 19563660
Pediatr Allergy Immunol. 2010 Jun;21(4 Pt 2):e723-32
pubmed: 20444151
Environ Int. 2017 Apr;101:190-200
pubmed: 28202226
Clin Exp Allergy. 2013 Dec;43(12):1406-18
pubmed: 24112543
Mol Med Rep. 2018 Jul;18(1):349-357
pubmed: 29749523
J Biol Chem. 2006 Jul 21;281(29):19906-15
pubmed: 16679317
J Allergy Clin Immunol. 2019 Apr;143(4):1560-1574.e6
pubmed: 30194990
J Allergy Clin Immunol. 2014 Feb;133(2):388-94
pubmed: 24075231
Am J Respir Crit Care Med. 2013 May 15;187(10):1085-90
pubmed: 23525930
Respir Res. 2010 Jan 21;11:7
pubmed: 20092634
Free Radic Biol Med. 2017 Nov;112:452-463
pubmed: 28843778
Chronic Dis Transl Med. 2018 Jun 08;4(2):95-102
pubmed: 29988900
Toxicology. 2004 Jul 1;199(2-3):261-5
pubmed: 15147799
Blood. 2013 Apr 18;121(16):3195-204
pubmed: 23462117
Toxicology. 2012 Jan 27;291(1-3):25-31
pubmed: 22051199
Hum Exp Toxicol. 2017 Apr;36(4):349-364
pubmed: 27206700
Environ Epigenet. 2018 Jul 27;4(3):dvy020
pubmed: 30090644
Inflammation. 2014 Apr;37(2):387-95
pubmed: 24092408
Am J Respir Cell Mol Biol. 2015 Jan;52(1):106-15
pubmed: 24988374
J Allergy Clin Immunol. 2014 Jul;134(1):73-4
pubmed: 24835501
J Thorac Dis. 2017 Jan;9(1):E32-E43
pubmed: 28203435
J Invest Dermatol. 2005 Nov;125(5):962-8
pubmed: 16297197
J Exp Med. 2009 Aug 31;206(9):2027-35
pubmed: 19703987
Ecotoxicol Environ Saf. 2018 May 15;152:42-54
pubmed: 29407781
Clin Exp Allergy. 2000 Jul;30(7):972-8
pubmed: 10848919
J Immunol. 2008 Aug 15;181(4):2790-8
pubmed: 18684970
PLoS One. 2013;8(1):e51268
pubmed: 23300949
Infect Immun. 2016 Sep 19;84(10):3071-82
pubmed: 27481250
Nature. 2008 May 1;453(7191):106-9
pubmed: 18362914
Mediators Inflamm. 2014;2014:591479
pubmed: 24795504
Lancet. 2014 May 3;383(9928):1581-92
pubmed: 24792855
Allergy. 2015 May;70(5):556-67
pubmed: 25683166
J Immunol. 2018 Oct 15;201(8):2221-2231
pubmed: 30185520
Curr Opin Immunol. 2015 Jun;34:52-8
pubmed: 25705788
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Immunol. 2018 Aug 1;201(3):916-929
pubmed: 29967100
J Clin Immunol. 2008 Mar;28(2):147-56
pubmed: 18049884
Am J Respir Crit Care Med. 2015 Aug 1;192(3):337-41
pubmed: 26017067
Toxicol Lett. 2005 May 16;157(1):31-9
pubmed: 15795091
Nat Immunol. 2013 Jun;14(6):536-42
pubmed: 23685824
Sci Transl Med. 2016 May 4;8(337):337ra65
pubmed: 27147589
J Allergy Clin Immunol. 2018 Feb;141(2):586-600.e6
pubmed: 28689792
FEBS Lett. 2005 Mar 28;579(9):1904-10
pubmed: 15792794
Biosci Rep. 2018 Sep 12;38(5):
pubmed: 29899163
Sci Transl Med. 2013 Jul 24;5(195):195ra97
pubmed: 23884469
Nature. 2014 Jul 10;511(7508):184-90
pubmed: 24930766
J Immunol. 2005 Jun 15;174(12):8183-90
pubmed: 15944327
Allergy. 2019 Sep;74(9):1675-1690
pubmed: 30982974
J Immunol. 2010 Dec 1;185(11):6636-45
pubmed: 20974985

Auteurs

Eryi Wang (E)

The Affiliated Luohu Hospital of Shenzhen University, Shenzhen Luohu Hospital Group, Shenzhen, China.
The State Key Laboratory of Respiratory Disease for Allergy, Shenzhen University School of Medicine, Shenzhen University, Shenzhen, China.

Xiaoyu Liu (X)

The State Key Laboratory of Respiratory Disease for Allergy, Shenzhen University School of Medicine, Shenzhen University, Shenzhen, China.

Wei Tu (W)

The Affiliated Luohu Hospital of Shenzhen University, Shenzhen Luohu Hospital Group, Shenzhen, China.
The State Key Laboratory of Respiratory Disease for Allergy, Shenzhen University School of Medicine, Shenzhen University, Shenzhen, China.

Danh C Do (DC)

Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Haiqiong Yu (H)

The Affiliated Luohu Hospital of Shenzhen University, Shenzhen Luohu Hospital Group, Shenzhen, China.

Liteng Yang (L)

The Affiliated Luohu Hospital of Shenzhen University, Shenzhen Luohu Hospital Group, Shenzhen, China.

Yufeng Zhou (Y)

Key Laboratory of Neonatal Disease, Ministry of Health, Children's Hospital and Institute of Biomedical Sciences, Fudan University, Shanghai, China.

Damo Xu (D)

Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.

Shau-Ku Huang (SK)

The Affiliated Luohu Hospital of Shenzhen University, Shenzhen Luohu Hospital Group, Shenzhen, China.
Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
National Institute of Environmental Health Sciences, National Health Research Institutes, Miaoli, Taiwan.

Pingchang Yang (P)

The Affiliated Luohu Hospital of Shenzhen University, Shenzhen Luohu Hospital Group, Shenzhen, China.
The State Key Laboratory of Respiratory Disease for Allergy, Shenzhen University School of Medicine, Shenzhen University, Shenzhen, China.

Pixin Ran (P)

Guangzhou Institute of Respiratory Disease, State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Pei-Song Gao (PS)

Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Zhigang Liu (Z)

The Affiliated Luohu Hospital of Shenzhen University, Shenzhen Luohu Hospital Group, Shenzhen, China.
The State Key Laboratory of Respiratory Disease for Allergy, Shenzhen University School of Medicine, Shenzhen University, Shenzhen, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH